140
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

The effects of DNA repair polymorphisms on chromosome aberrations in the population of Kazakhstan

, , , & ORCID Icon
Pages 614-621 | Received 26 Jul 2019, Accepted 20 Dec 2019, Published online: 21 Jan 2020

References

  • Andreassen CN, Rosenstein BS, Kerns SL, Ostrer H, De Ruysscher D, Cesaretti JA, Barnett GC, Dunning AM, Dorling L, West CML, et al. 2016. Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. Radiother Oncol. 121:431–439.
  • Au WW, Navasumrit P, Ruchirawat M. 2004. Use of biomarkers to characterize functions of polymorphic DNA repair genotypes. Int J Hyg Environ Health. 207:301–313.
  • Au WW, Salama S, Sierra-Torres CH. 2003. Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect. 111:1843–1850.
  • Barrett JH, Iles MM, Harland M, Taylor JC, Aitken JF, Andresen PA, Akslen LA, Armstrong BK, Avril MF, Azizi E, et al. 2011. Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet. 43:1108–1113.
  • Bauchinger M. 1995. Quantification of low-level radiation exposure by conventional chromosome aberration analysis. Mutat Res. 339:177–189.
  • Bernstein JL, Concannon P; WECARE Study Collaborative Group. 2017. ATM, radiation, and the risk of second primary breast cancer. Int J Radiat Biol. 93:1121–1127.
  • Bignold LP. 2009. Mechanisms of clastogen-induced chromosomal aberrations: a critical review and description of a model based on failures of tethering of DNA strand ends to strand-breaking enzymes. Mutat Res. 681:271–298.
  • Bolegenova NK, Bekmanov BO, Djansugurova LB, Bersimbaev RI, Salama SA, Au WW. 2009. Genetic polymorphisms and expression of minisatellite mutations in a 3-generation population around the Semipalatinsk nuclear explosion test-site, Kazakhstan. Int J Hyg Environ Health. 212:654–660.
  • Borràs-Fresneda M, Barquinero JF, Gomolka M, Hornhardt S, Rössler U, Armengol G, Barrios L. 2016. Differences in DNA repair capacity, cell death and transcriptional response after irradiation between a radiosensitive and a radioresistant cell line. Sci Rep. 6:27043.
  • Chaizhunusova N, Madiyeva M, Tanaka K, Hoshi M, Kawano N, Noso Y, Takeichi N, Rakhypbekov T, Urazalina N, Dovgal G, et al. 2017. Cytogenetic abnormalities of the descendants of permanent residents of heavily contaminated East Kazakhstan. Radiat Environ Biophys. 56:337–343.
  • Chistiakov DA, Voronova NV, Chistiakov PA. 2008. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients. Acta Oncol. 47:809–824.
  • Dong L, Cui J, Tang F, Cong X, Han F. 2015. Ataxia telangiectasia mutated gene polymorphisms and acute normal tissue injuries in cancer patients after radiation therapy: a systematic review and meta-analysis. Int J Radiat Oncol. 91:1090–1098.
  • Du L, Yu W, Dai X, Zhao N, Huang X, Tong F, Liu F, Huang Y, Ju Z, Yang W, et al. 2017. Association of DNA repair gene polymorphisms with the risk of radiation pneumonitis in lung cancer patients. Oncotarget. 9:958–968.
  • Dubrova YE, Bersimbaev RI, Djansugurova LB, Tankimanova MK, Mamyrbaeva ZZ, Mustonen R, Lindholm C, Hultén M, Salomaa S. 2002. Nuclear weapons tests and human germline mutation rate. Science. 295:1037–1037.
  • Durante M, Bedford JS, Chen DJ, Conrad S, Cornforth MN, Natarajan AT, van Gent DC, Obe G. 2013. From DNA damage to chromosome aberrations: joining the break. Mutat Res. 756:5–13.
  • Feng YZ, Liu YL, He XF, Wei W, Shen XL, Xie DL. 2014. Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case–control studies. Tumor Biol. 35:10677–10697.
  • Greenberger JS, Berhane H, Shinde A, Rhieu BH, Bernard M, Wipf P, Skoda EM, Epperly MW. 2014. Can radiosensitivity associated with defects in DNA repair be overcome by mitochondrial-targeted antioxidant radioprotectors. Front Oncol. 4:24
  • Grosche B. 2002. Semipalatinsk test site: introduction. Radiat Environ Biophys. 41:53–55.
  • Grosche B, Zhunussova T, Apsalikov K, Kesminiene A. 2015. Studies of health effects from nuclear testing near the Semipalatinsk nuclear test site, Kazakhstan. Cent Asian J Glob Health. 4:127
  • Hartl DL, Clark AG. 2007. Principles of population genetics. 4th ed. Sunderland (MA): Sinauer Associates.
  • He XF, Wei W, Li JL, Shen XL, Ding DP, Wang SL, Liu ZZ, Qin JB, Wu LX, Xie DL. 2013. Association between the XRCC3 T241M polymorphism and risk of cancer: evidence from 157 case–control studies. Gene. 523:10–19.
  • Kabacik S, Manning G, Raffy C, Bouffler S, Badie C. 2015. Time, dose and ataxia telangiectasia mutated (ATM) status dependency of coding and noncoding RNA expression after ionizing radiation exposure. Radiat Res. 183:325–337.
  • Kurz EU, Lees-Miller SP. 2004. DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair (Amst). 3:889–900.
  • Kweekel DM, Antonini NF, Nortier JWR, Punt CJA, Gelderblom H, Guchelaar HJ. 2009. Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array. Br J Cancer. 101:357–362.
  • Langholz B, Bernstein JL, Bernstein L, Olsen JH, Børresen-Dale AL, Rosenstein BS, Gatti RA, Concannon P, The WECARE Study Collaborative Group. 2006. On the proposed association of the ATM variants 5557G > A and IVS38-8T > C and bilateral breast cancer. Int J Cancer. 119:724–725.
  • Lindholm C, Murphy BP, Bigbee WL, Bersimbaev RI, Hulten MA, Dubrova YE, Salomaa S. 2004. Glycophorin A somatic cell mutations in a population living in the proximity of the Semipalatinsk Nuclear Test Site. Radiat Res. 162:64–170.
  • Matsuschenko AM, Tsyrkov GA, Chernyshov AK, Dubasov YV, Krasilov GA, Logachev VA, Smagulov SG, Tsaturov YS, Zelentsov SA. 1998. Chronological list of nuclear tests at the Semipalatinsk Test Site and their radiation effects. In: Shapiro CS, Kiselev VI, Zaitsev EV, editors. Nuclear tests. Long-term consequences in the Semipalatinsk/Altai region, Berlin: Springer. p. 89–97.
  • Natarajan AT, Palitti F. 2008. DNA repair and chromosomal alterations. Mutat Res. 657:3–7.
  • Norpa H. 2004. Cytogenetic biomarkers and genetic polymorphism. Toxicol Lett. 149:309–334.
  • Obe G, Pfeiffer P, Savage JRK, Johannes C, Goedecke W, Jeppesen P, Natarajan AT, Martı́nez-López W, Folle GA, Drets ME. 2002. Chromosomal aberrations: formation, identification and distribution. Mutat Res. 504:17–36.
  • Pratesi N, Mangoni M, Mancini I, Paiar F, Simi L, Livi L, Cassani S, Buglione M, Grisanti S, Almici C, et al. 2011. Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. Radiother Oncol. 99:356–361.
  • Rakhypbekov TK. 2009. The health status of the population in the Semey region and scientifically proven measures to improve it. In: Nakashima M, Takamura N, Tsukasaki K, Nagayama Y, Yamashita S, editors. Radiation health risk sciences. Tokyo: Springer, p. 322–327.
  • Sakaguchi A, Yamamoto M, Hoshi M, Imanaka T, Apsalikov KN, Gusev BI. 2006. Radiological situation in the vicinity of Semipalatinsk nuclear test site: Dolon, Mostik, Cheremushka and Budene Settlements. JRR. 47:A101–A116.
  • Salomaa S, Lindholm C, Tankimanova MK, Mamyrbaeva ZZ, Koivistoinen Z, Hultén M, Mustonen R, Dubrova YE, Bersimbaev RI. 2002. Stable chromosome aberrations in the lymphocytes of a population living in the vicinity of the Semipalatinsk Nuclear Test Site. Radiat Res. 158:591–596.2.0.CO;2]
  • Shiloh Y, Ziv Y. 2013. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol. 14:197–210.
  • Sigurdson A J, Ha M, Hauptmann M, Bhatti P, Sram R J, Beskid O, Tawn E. J, Whitehouse C A, Lindholm C, Nakano M, et al. 2008. International study of factors affecting human chromosome translocations. Mutat Res. 652:112–121.
  • Song YZ, Duan MN, Zhang YY, Shi WY, Xia CC, Dong LH. 2015a. ERCC2 polymorphisms and radiation induced adverse effects on normal tissue: systematic review with meta-analysis and trial sequential analysis. Radiat Oncol. 10:247.
  • Song YZ, Han FJ, Liu M, Xia CC, Shi WY, Dong LH. 2015b. Association between single nucleotide polymorphisms in XRCC3 and radiation-induced adverse effects on normal tissue: a meta-analysis. PLoS One. 10:e0130388.
  • Spitz MR, Wu X, Wang Y, Wang LE, Shete S, Amos CI, Guo Z, Lei L, Mohrenweiser H, Wei Q. 2001. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res. 61:1354–1357.
  • Taira Y, Hayashida N, Brahmanandhan GM, Nagayama Y, Yamashita S, Takahashi J, Gutevitc A, Kazlovsky A, Urazalin M, Takamura N. 2011. Current concentration of artificial radionuclides and estimated radiation doses from 137Cs around the Chernobyl Nuclear Power Plant, the Semipalatinsk Nuclear Testing Site, and in Nagasaki. JRR. 52:88–95.
  • Vakulchuk R, Gjerde K, Belikhina T, Apsalikov K. 2014. Semipalatinsk nuclear testing: the humanitarian consequences. NUPI Report no. 1.
  • Vodicka P, Musak L, Frank C, Kazimirova A, Vymetalkova V, Barancokova M, Smolkova B, Dzupinkova Z, Jiraskova K, Vodenkova S, et al. 2015. Interactions of DNA repair gene variants modulate chromosomal aberrations in healthy subjects. Carcinogenesis. 36:1299–1306.
  • Wilding CS, Relton CL, Rees GS, Tarone RE, Whitehouse CA, Tawn EJ. 2005. DNA repair gene polymorphisms in relation to chromosome aberration frequencies in retired radiation workers. Mutat Res. 570:137–145.
  • Wu KG, He XF, Li YH, Xie WB, Huang X. 2014. Association between the XPD/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case–control studies. Tumor Biol. 35:11243–11259.
  • Xiao F, Pu J, Wen Q, Huang Q, Zhang Q, Huang B, Huang S, Lan A, Zhang Y, Li J, et al. 2017. Association between the ERCC2 Asp312Asn polymorphism and risk of cancer. Oncotarget. 8:48488–48506.
  • Yi L, Xiao-Feng H, Yun-Tao L, Hao L, Ye S, Song-Tao Q. 2013. Association between the XRCC1 Arg399Gln polymorphism and risk of cancer: evidence from 297 case–control studies. PLoS One. 8:e78071.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.